Canada Diabetes Industry Report to 2028: Featuring Medtronic, Insulet, LifeScan and Abbott Laboratories Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Canada Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Canada's Diabetes Market will reach US$ 1.53 Billion by 2028 with a CAGR of 3.85% during the forecast period (2023-2028), according to the publisher.

Company Analysis

• Medtronic
• Insulet Corporation
• LifeScan Inc.
• Abbott Laboratories
• Dexcom, Inc
• Roche Diagnostic
• Tandem Diabetes Care

Diabetes is one of Canada's most prevalent chronic diseases, with over 11.7 million people with diabetes or prediabetes each year. It poses many challenges, such as serious complications and premature death for those affected by diabetes, and impacts health care systems. In all types of diabetes, the human body does not produce enough insulin or use the insulin it makes effectively. Therefore, each type may differ concerning its potential causes, prognosis, and treatment.

The Canadian Diabetes Industry is driven by the growing rate of obesity, spurring stress levels, and inefficient exercise within the country. The industry is further aided by the increasing high demand for insulin, which has resulted in huge R&D activities in producing various painless types of deliverable devices, like continuous glucose monitoring (CGM), integrated insulin pumps, improved new lancets products for a blood glucometer, and enormously accurate blood glucose monitoring devices.

The Canadian diabetes market is witnessing tremendous growth due to various new advancements taking place in the diabetes industry. Initially, the insulin was given through syringes, which were considered painful and hard to use. The only drawback that might affect the Canadian diabetes industry growth is the high cost of insulin pens. Canadian diabetes market was valued at US$ 1.22 Billion in 2022.

Continued Rising Trend of Type 2 Diabetes Rates in Canada

Type 2 diabetes is one of the fastest-growing diseases in Canada. As a result, Canada has an unprecedented opportunity to implement innovative policy and exercise global leadership with bold action on diabetes. Approximately 90% of all diabetes diagnoses are type 2 diabetes. In addition, Type 2 has a substantial economic burden attributable to severe micro vascular and macro vascular complications.

Moreover, More than 300,000 Canadians live with Type 1 diabetes, a chronic disease requiring patients to inject insulin and test their blood sugar throughout the day. In Dec 2021, The UBC Faculty of Medicine launched Canada's first JDRF Centre of Excellence in Type 1 diabetes research.

SMBG Devices will grow more in the Upcoming Years

Canada's Diabetes industry was classified into CGM, SMBG, and Insulin Pumps. Self-Blood glucose monitoring (SBGM) devices are helpful for patients with diabetes. SMBG is subdivided into a blood glucose meter, testing strips, and lancets. SMBG systems are small and easy to use, require small blood sample volumes, and provide measurement results within seconds.

In addition, devices are increasingly equipped with connectivity to other devices, digital diaries, and diabetes management tools. CGM and Insulin pumps are also growing daily due to growing awareness about diabetes preventive care, new product launches, and supportive government initiatives.

Canada Government Initiative

The high prevalence of diabetes and its overwhelming impact on Canadian communities and the healthcare system means that further diabetes research is needed. In 2021, Canadian Government announced US$ 35 Million for five years for prevention, surveillance, and research to work development of a national framework for diabetes.

Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. Canada Diabetes Market

6. Canada Diabetes Population

6.1 Type 1 Diabetes

6.2 Type 2 Diabetes

7. Market Share - Canada Diabetes Analysis

7.1 By Types

8. Continuous Glucose Monitoring Market (CGM) - Canada Market & Users

8.1 Canada- CGM Market by Components

8.1.1 Glucose Sensor Market

8.1.2 CGM Transmitter Market

8.2 CGM User

8.3 Reimbursement Policies of CGM Devices in Canada

9. Blood Glucose Device (SMBG) - Canada Market & Users

9.1 Market

9.1.1 Type 1 Diabetes Market

9.1.2 Type 2 Diabetes Market

9.2 Test Strips Market

9.2.1 Type 1 Diabetes

9.2.2 Type 2 Diabetes

9.3 Lancet Market

9.3.1 Type 1 Diabetes

9.3.2 Type 2 Diabetes

9.4 Meter Market and Forecast

9.4.1 Type 1 Diabetes

9.4.2 Type 2 Diabetes

9.5 Blood Glucose (SMBG) Users

9.5.1 Type 1 Diabetes

9.5.2 Type 2 Diabetes

9.6 Reimbursement Policies of Blood Glucose Devices in Canada

10. Insulin Pump -Canada Market & Users

10.1 Insulin Pump Market

10.1.1 Type 1 Diabetes Market

10.1.2 Type 2 Diabetes Market

10.2 Insulin Pump User

10.2.1 Type 1 Insulin Pump User

10.2.2 Type 2 Insulin Pump User

10.3 Differentiation Points of Insulin Pump Products in Canada

10.3.1 Animas Vibe

10.3.2 Medtronic 530G with Enlite

10.3.3 Insulet OmniPod

10.3.4 Tandem t: slim

10.3.5 Roche Accu-Chek Combo

10.4 Training Model ( Medtronic, Animas, Insulet Corp &Training to Patients & HCP)

10.4.1 Medtronic

10.4.1.1 Training Guidelines for Insulin Pump Therapy to New Patients

10.4.1.2 Training Model for HCP (HealthCare Professional)

10.5 Insulet Corporation

10.5.1 Training Structure for New Patients - Insulet Corporation

10.6 Animas Corporation

10.6.1 Training Modules for New Patients

10.6.2 Training Modules for HCP (Health Care Professional)

10.7 Tandem Diabetes Care

10.8 Reimbursement Policies Insulin Pump

11. Insulin Pump - Company Analysis

12. SMBG - Company Analysis

13. CGM - Company Analysis

For more information about this report visit https://www.researchandmarkets.com/r/ibcd83-diabetes?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.